See also this year's filing and all EDGAR filings for this company.
PDF Report 0001880438_2023_AN2_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100040 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 9, '100050 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 2': 2}} |
Graph
Absolute values for 0001880438, AN2 Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 98,621,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 3,939,000 |
| 4 | LiabilitiesCurrent | 7,186,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 2,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,751,000 |
| 9 | ResearchAndDevelopmentExpense | 28,511,000 |
| 10 | remainder_Expenses | 1,000,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,306,000 |
| 13 | remainder_ComprehensiveNetIncome | -347,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 102,560,000 |
| 1 | Liabilities | 7,188,000 |
| 2 | Expenses | 42,262,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 95,372,000 |
| 5 | NetIncome | -40,956,000 |
| 6 | ComprehensiveNetIncome | -41,129,500 |
| 7 | BaseVar | 76,831,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.04 |
| 9 | EconomicCapitalRatio | 3.71 |
Edgar->Model Mapping
Feature Distribution
